INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 100 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 2.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $2,000 | -50.0% | 166 | -52.6% | 0.00% | – |
Q4 2016 | $4,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q3 2016 | $4,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q2 2016 | $4,000 | -33.3% | 350 | 0.0% | 0.00% | – |
Q1 2016 | $6,000 | -40.0% | 350 | 0.0% | 0.00% | – |
Q4 2015 | $10,000 | +11.1% | 350 | +5.4% | 0.00% | – |
Q3 2015 | $9,000 | -98.8% | 332 | -98.5% | 0.00% | -100.0% |
Q2 2015 | $774,000 | +6936.4% | 21,561 | +8098.1% | 0.00% | – |
Q1 2014 | $11,000 | -98.4% | 263 | -98.5% | 0.00% | -100.0% |
Q4 2013 | $670,000 | +106.8% | 17,345 | +87.1% | 0.00% | +100.0% |
Q3 2013 | $324,000 | – | 9,271 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
GAM Holding AG | 83,940 | $808,000 | 0.02% |
SFMG, LLC | 11,994 | $115,000 | 0.02% |
SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |